Abbott | ABT - Aktuelle Verpflichtungen

Aktienkurs
91.13
Täglich Wechseln
-1.35 -1.46%
Monatlich
-13.07%
Jährlich
-29.27%
Q2 Prognose
94.68




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Agilent USD 2.23B 113M 2025-12
AtriCure USD 81.52M 3.68M 2025-12
Baxter International USD 2.97B 805M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Boston Scientific USD 5.44B 111M 2025-12
Cooper Companies USD 1.6B 482.9M 2025-12
Danaher USD 7.46B 653M 2026-03
Dexcom USD 2.14B 1.19B 2025-12
Edwards Lifesciences USD 1.81B 225.7M 2025-12
Globus Medical USD 498.5M 32.54M 2025-12
Insulet USD 680.1M 32.4M 2025-12
Integra LifeSciences USD 455.98M 91.93M 2025-12
Intuitive Surgical USD 2.51B 3.2M 2026-03
J&J USD 57.72B 3.59B 2026-03
Masimo USD 371.6M 1.9M 2025-12
Medtronic USD 9.5B 440M 2025-12
Merit Medical Systems USD 239.76M 9.29M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Smith & Nephew USD 1.54B 236M 2025-12
Solventum Corp USD 3.14B 198M 2025-12
Stryker USD 7.79B 380M 2025-12
Tandem Diabetes Care USD 242.72M 9.82M 2025-12
Teleflex USD 762.03M 11.01M 2025-12
Terumo JPY 539.7B 243.4B 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Zimmer Biomet Holdings USD 2.58B 180.8M 2025-12